Centro de Investigaciones Endocrinológicas, División de Endocrinología, Hospital de Niños R. Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, Argentina.
J Clin Endocrinol Metab. 2010 Jun;95(6):2811-8. doi: 10.1210/jc.2009-2732. Epub 2010 Apr 6.
Differential diagnosis between hypogonadotropic hypogonadism (HH) and constitutional delay of puberty in boys is challenging. Most tests use an acute GnRH stimulus, allowing only the release of previously synthesized gonadotropins. A constant GnRH infusion, inducing de novo gonadotropin synthesis, may allow a better discrimination.
We evaluated the diagnostic accuracy of basal and peak gonadotropins after GnRH infusion, measured by ultrasensitive assays, to confirm the diagnosis in boys with suspected HH.
We conducted a validation study following Standards for Reporting of Diagnostic Accuracy criteria at a tertiary public hospital.
A GnRH i.v. infusion test was performed in 32 boys. LH and FSH were determined by immunofluorometric assay at 0-120 min. DIAGNOSIS ASCERTAINMENT: The following diagnoses were ascertained: complete HH (n = 19; testes < 4 ml at 18 yr), partial HH (n = 6; testes enlargement remained arrested for > or = 1 yr or did not reach 15 ml), and constitutional delay of puberty (n = 7; testes > or = 15 ml at 18 yr).
Sensitivity, specificity, positive and negative predictive values, and diagnostic efficiency were assessed.
Basal FSH less than 1.2 IU/liter confirmed HH with specificity of 1.00 (95% confidence interval = 0.59-1.00), rendering GnRH infusion unnecessary. In patients with basal FSH of at least 1.2 IU/liter, the coexistence of peak FSH less than 4.6 IU/liter and peak LH less than 5.8 IU/liter after GnRH infusion had high specificity (1.00; 95% confidence interval = 0.59-1.00) and diagnostic efficiency (76.9%) for HH.
Basal FSH less than 1.2 IU/liter confirms HH, which precludes from further testing, reducing patient discomfort and healthcare system costs. In patients with basal FSH of at least 1.2 IU/liter, a GnRH infusion test has a high diagnostic efficiency.
在男性中,促性腺激素低下性性腺功能减退症(HH)与体质性青春期延迟的鉴别诊断具有挑战性。大多数测试使用急性 GnRH 刺激,仅允许先前合成的促性腺激素释放。持续 GnRH 输注可诱导新的促性腺激素合成,可能有助于更好地区分。
我们通过超敏测定评估 GnRH 输注后基础和峰值促性腺激素的诊断准确性,以确认疑似 HH 的男孩的诊断。
我们在一家三级公立医院按照诊断准确性报告标准进行了验证研究。
对 32 名男孩进行 GnRH 静脉内输注试验。LH 和 FSH 通过免疫荧光测定在 0-120 分钟时测定。诊断确定:确定以下诊断:完全 HH(n = 19;18 岁时睾丸<4ml)、部分 HH(n = 6;睾丸增大仍停滞>或=1 年或未达到 15ml)和体质性青春期延迟(n = 7;18 岁时睾丸>或=15ml)。
评估敏感性、特异性、阳性和阴性预测值以及诊断效率。
基础 FSH<1.2IU/l 可确定 HH 的特异性为 1.00(95%置信区间=0.59-1.00),无需进行 GnRH 输注。在基础 FSH 至少为 1.2IU/l 的患者中,GnRH 输注后峰值 FSH<4.6IU/l 和峰值 LH<5.8IU/l 的共存对 HH 具有高特异性(1.00;95%置信区间=0.59-1.00)和诊断效率(76.9%)。
基础 FSH<1.2IU/l 可确定 HH,从而排除进一步的测试,减少患者不适和医疗保健系统成本。在基础 FSH 至少为 1.2IU/l 的患者中,GnRH 输注试验具有高诊断效率。